Atlas Trials

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Clinical trial NCT05451771 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05451771
Sponsor
Columbia University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
AL Amyloidosis
Start date
2022-10-26
Primary completion
2027-09-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.